Pathogenesis of High-Altitude Pulmonary Edema

Authors:
  • MMMarco Maggiorini
    Marco Maggiorini
  • SMStephen Mongovin
    Stephen Mongovin
  • JGJ. Simon R. Gibbs
    J. Simon R. Gibbs
  • IGIlona Greve
    Ilona Greve
  • HMHeimo Mairbäurl
    Heimo Mairbäurl
  • PBPeter Bärtsch
    Peter Bärtsch

Abstract
High-altitude pulmonary edema (HAPE) is a life-threatening illness in climbers and tourists ascending to altitudes higher than 2500 m. The pathogenesis of this unique form of pulmonary edema that occurs rapidly in otherwise healthy people has not been entirely illuminated owing to the difficulties of studying the disease early in its evolution and to conflicting data from animal and human investigations. The central issue is whether the alveolar-capillary leak in HAPE is caused by high microvascular pressures or inflammation. Besides revealing a more definitive answer about HAPE itself, resolution of this question may facilitate our understanding, diagnosis, and treatment of other common forms of pulmonary edema, such as congestive heart failure and adult respiratory distress syndrome.

This publication has 35 references indexed in Scilit: